in 2026, Bank Indonesia Plans to Roll Over 173.4 Trln Rupiah in Maturing Govt Bonds to New Bonds - Joint Statement From Cenbank, Govt
the Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
South Korea Industry Ministry: Consultation With U.S. on Trade Deal Implementation to Continue in Favourable Manner
AWS: Identified Root Cause of Connectivity Issues to US-East-1 Region, Actively Working to Mitigate Issue
Reminder: Beyond Meat, Inc. Investors With Significant Losses Must Act by March 24, 2026
Rakovina Therapeutics Announces Upsized Financing up to $2.0 Million
AWS: We Are Investigating Connectivity Loss Impacting AWS Direct Connect Connectivity to the US-East-1 Region
Westshore Terminals Announces $165 Million Credit Facility
Brazil's Copasa: BTG Pactual, Itau Bba, Bofa, Citi and UBS Bb Tapped as Bookrunners of Copasa's Potential Share Offering - Filing
Smartstop Self Storage REIT Announces Appointment of New Management Board Member
Txnm Energy Inc - Hart-Scott-Rodino Period for Acquisition Expired
Ferc Authorizes Txnm Energy Acquisition by Blackstone Infrastructure, Finds Transaction Consistent With Public Interest
Vanda Pharmaceuticals Inc: Includes Warning for Bysanti, Increased Mortality in Elderly Patients With Dementia-Related Psychosis
Vanda Pharmaceuticals Announces FDA Approval of Bysanti™ (Milsaperidone) for the Treatment of Bipolar I Disorder and Schizophrenia - a New Chemical Entity Opening New Horizons in Psychiatric Innovation
Vanda Pharmaceuticals Inc - Bysanti Expected to Be Commercially Available in Q3 2026